Explore our materials

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Pro Standpoint | Nancy Reau, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Long Acting Antivirals: Advanced drug delivery | Mark Milad, PharmD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

DDI’s in Aging HCV infected Patients | Elise Smolders, MSc

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

FDA perspective | Kellie Reynolds, PharmD

Jordan Feld

MD, MPH

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Clinical Aspects of Pediatric Treatment | Tim Cressey, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Current Challenges in Pediatric Drug Development | Robert Ward, MD, FAAP, FCP

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Current and Future Treatment of CMV | Robin Avery, MD

Ishwar Gilada

MD, DDV, FCPS

Asia-Pacific HIV Clinical Forum 2017

Clinical case presentation | Ishwar Gilada, MD, DDV, FCPS

Asia-Pacific HIV Clinical Forum 2017

Clinical case presentation | Dr. Wilson Lam

Charles Boucher

MD, PhD

Asia-Pacific HIV Clinical Forum 2017

HIV Macroprevention, epidemiology, phylogenics and networks | Charles Boucher, MD, PhD

Daniel Kuritzkes